Company Overview and News

1
USO Finds Resistance At $15 - Is There Fuel For A New High?

2018-09-16 seekingalpha
USO has enough fuel for a push past $15, for reasons stated below, which investors should not bet against.
USO NOV CTLR CLR

1
Top 3 Ways To Play USO While Delays In Completions Persist

2018-09-12 seekingalpha
USO is on the verge of a breakout, and is the pure way to play an energy recovery.
FRAC APC PIO USO NOV CTLR CLR PIONF AEUA

35
3 Big Stock Charts for Tuesday: Intel, National-Oilwell Varco and ONEOK

2018-09-11 investorplace
The market mustered a modest gain of 0.19% on Monday, reversing last week’s sizable setback. Don’t be fooled though. Stocks struggled to hold onto their solid open, closing well below it as well as below the high for the day.
BABA NOV AAPL AMD OKE INTC

1
Continental Resources Thriving While Others Delay Completions

2018-09-11 seekingalpha
Widening differentials continue to be a non-factor for CLR, since they operate in less crowded basins that have adequate takeaway capacity.
NOV CTLR CLR

23
Top Analyst Upgrades and Downgrades: Baker Hughes, CBS, Generac, Halliburton, Nike, PG&E, Snap, Tesla, Weatherford, Western Digital and More

2018-09-11 247wallst
Stocks were indicated to open lower on Tuesday morning as continued profit-taking in September is a theme. Despite the choppy markets, it’s important to know that the major stock market indexes are still quite close to all-time highs. Investors also need to consider that buying the sell-offs has so far in 2018 been less rewarding than in prior years.
PCG HAL NOV WDC NKE GNRC EGN AEP MYGN MS CBS CBS.A BHGE CBS.WD BHI CZR TRI CPV FANG

1
U.S. Silica Not Given Enough Credit For Sandbox

2018-09-06 seekingalpha
U.S. Silica is done spending on major CapEx projects, and is set to earn considerable cashflow in the coming quarters, yet the stock has fallen to near 2016 lows.
FRAC WLL NOV

1
National Oilwell Varco Delivers On Cue, Transformation Process Underway

2018-09-05 seekingalpha
NOV finally reported a profit after four consecutive quarters of losses, representing a possible inflection point in earnings.
NOV

14
Flotek Industries Is Making Adjustments For A Solid Recovery

2018-08-31 seekingalpha - 1
Flotek Industries (FTK) provides chemistry and services that are used in the oil and gas industries and in the consumer and industrial markets. In 2018, so far, Flotek Industries' stock price has dipped by 53%, while VanEck Vectors Oil Services ETF (OIH) declined 4%. OIH represents the oilfield equipment & services (or OFS) industry. FTK has some near-term challenges from the operational perspective as well as some structural headwinds.
NOV FTK

1
Why Is National Oilwell Varco (NOV) Up 5.3% Since Last Earnings Report?

2018-08-27 zacks
A month has gone by since the last earnings report for National Oilwell Varco (NOV - Free Report) . Shares have added about 5.3% in that time frame, outperforming the S&P 500.
NOV BOKF

1
Stena Getting Offshore Rigs Back to Work with Simulators

2018-08-06 rigzone
Seeking to make rig reactivations faster, smoother and safer for new and experienced crews alike, one offshore drilling contractor reported Monday that it is taking the unprecedented step of using simulators.
NOV

1
Northwest Pipe Acquires Ameron Water In Opportunistic Deal

2018-08-02 seekingalpha
Ameron provides a range of water and wastewater pipe products for infrastructure and other industries globally.
NOV

1
Nabors Industries Ltd (NBR) CEO Anthony Petrello on Q2 2018 Results - Earnings Call Transcript

2018-08-01 seekingalpha
Good morning and welcome to the Nabors Second Quarter 2018 Earnings Conference Call. [Operator Instructions]. Please note, this event is being recorded.
NOV NBR

48
Top Analyst Upgrades and Downgrades: Athenahealth, Illumina, Northrop Grumman, Square, Twitter, Yamana Gold and More

2018-07-31 247wallst - 1
Stocks were indicated to open marginally higher on Tuesday morning after a larger sell-off on Monday. Investors have been having less success buying the stock market dips in 2018 than in prior years. Many investors also are reconsidering how they want their investments positioned ahead of the midterm elections and during international trade concerns.
NTRI DB SQNXF YRI CHKVP NOV ILMN CHKDH CHKVZ CHKDG NOC TJX CHKDJ CHKDP AUY TWTR CKRGZ SQ BMRN CHKWZ ALLY CHK.WI CHK TRI ATHN

1
National Oilwell Varco, Inc. 2018 Q2 - Results - Earnings Call Slides

2018-07-30 seekingalpha
The following slide deck was published by National Oilwell Varco, Inc. in conjunction with their 2018 Q2 earnings call.
NOV

5
National Oilwell Varco (NOV) Soars: Stock Adds 10.3% in Session

2018-07-30 zacks
National Oilwell Varco, Inc. (NOV - Free Report) was a big mover last session, as the company saw its shares rise more than 10% on Friday. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $42.30 to $45.33 in the past one-month time frame. The move came after the company reported solid second-quarter 2018 results.
ALGN EDIT CNA NOV MDR MCDFF

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to NOV / National Oilwell Varco, Inc. on message board site Silicon Investor.

NNVC - NanoViricides, Inc. NNVC - NanoViricides, Inc. NNVC - NanoViricides, Inc. INO - Inovio Pharmaceuticals - A NYSE Small-Cap INO - Inovio Pharmaceuticals - A NYSE Small-Cap INO - Inovio Pharmaceuticals - A NYSE Small-Cap
NanoViricides - Nanobiotechnology NanoViricides - Nanobiotechnology NanoViricides - Nanobiotechnology Nanoviricides - The Other Board Nanoviricides - The Other Board Nanoviricides - The Other Board
Novavax NVAX Novavax NVAX Novavax NVAX Westport Inovations Westport Inovations Westport Inovations
NNVC - NanoViricides, Inc. (Bulls Board) NNVC - NanoViricides, Inc. (Bulls Board) NNVC - NanoViricides, Inc. (Bulls Board) Novartis Novartis Novartis
On Track Innovations Ltd. (OTIV) On Track Innovations Ltd. (OTIV) On Track Innovations Ltd. (OTIV) Novatel Wireless, Inc. NVTL Novatel Wireless, Inc. NVTL Novatel Wireless, Inc. NVTL
CUSIP: 637071101